X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-6-2024-62498.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-42-sodium-bicarbonate-injection-84-sodium-bicarbonate
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf
https://www.fiercepharma.com/pharma/specialty-injectables-maker-exela-issues-recall-after-particles-turn-3-different-drugs
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-84-sodium-bicarbonate-injection-usp-50
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-42-sodium-bicarbonate-injection-usp-and-1-and-2
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-26-2023-55742.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216364
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-21-2022-3491.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-expands-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-2-2022-77418.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/exela-pharma-sciences-llc-issues-voluntary-nationwide-recall-sodium-bicarbonate-injection-usp-84-50
https://www.pharmaceutical-technology.com/news/fda-approval-azurity-konvomep/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf
https://www.pharmacompass.com/pdf/news/sterrx-llc-issues-voluntary-nationwide-recall-of-sodium-bicarbonate-in-5-dextrose-injection-150meq-per-1000-ml-1628657130.pdf
https://www.in-pharmatechnologist.com/Article/2019/09/12/Civica-signs-agreement-with-Exela-for-medicine-supply
https://mk0sakunexoeoby9gsa0.kinstacdn.com/wp-content/uploads/2020/02/Civica.Exela-PR.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf
https://www.pharmacompass.com/pdf/news/Premier-Pharmacy-Labs-Issues-Voluntary-Nationwide-Recall-of-all-Unexpired-Sterile-Drug-Product-Lots-Due-to-Lack-of-Sterility-Assurance-1560923636.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-1-2019-1556686753.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-April-24-2019-1556080066.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-10-2019-1554872020.pdf
https://www.pharmacompass.com/pdf/news/hospira-inc-issues-a-voluntary-nationwide-recall-of-84-sodium-bicarbonate-injection-1552716619.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-16-2019-1547641914.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204558
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-18-2018-1531894333.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203345
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203449
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-September-20-2017-1505884449.pdf
https://www.pharmacompass.com/pdf/news/Bella-Pharmaceuticals-Inc-Issues-Voluntary-Nationwide-Recall-of-All-Sterile-Drug-Products-1503117778.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2017-1502256126.pdf
https://www.pharmacompass.com/pdf/news/pfizer-canada-inc-recalls-epipen-jr-due-to-malfunction-of-the-affected-lots-auto-injector-sodium-bicarbonate-inj-84-1497935323.pdf
http://www.fiercepharma.com/manufacturing/hospira-recall-vials-adds-to-woes-sodium-bicarbonate-shortage
https://www.pharmacompass.com/pdf/news/hospira-issues-a-voluntary-nationwide-recall-for-sodium-bicarbonate-succinylcholine-chloride-potassium-phosphates-injection-1497675971.pdf
http://www.fiercepharma.com/pharma/hospitals-scramble-for-sodium-bicarbonate-1-8-drugs-pfizer-says-it-currently-has-a-shortage
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202494
https://www.pharmacompass.com/pdf/news/suspended-lot-of-84-sodium-bicarbonate-from-samtec-1483441598.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207476
http://www.prnewswire.com/news-releases/perrigo-announces-fda-final-approval-and-launch-of-the-store-brand-equivalent-to-zegerid-otc-capsules-300299858.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ajanta-pharma-launches-acid-reflux-drug-in-us/articleshow/53263828.cms
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-launches-generic-acid-reflux-drug-in-us/articleshow/53269757.cms
https://www.pharmacompass.com/pdf/news/ajanta-pharmas-acid-reflux-drug-approved-in-us-1469101876.pdf
https://www.pharmacompass.com/pdf/news/actavis-receives-fda-nod-for-acid-reflux-drug-omeprazole-sodium-bicarbonate-1469101930.pdf
Market Place
Share 
